Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine dressing vs infiltration for skin graft donor site pain
NCT06766474Phase 2Completed
- Sponsor
- Minia University
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Minia University. Started Mar 2023; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06766474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06766474.